Clin Osteol 2016; 21(3): 89-91

Is obesity really a protective factor for osteoporosis?Short communications

Ľ. Cibičková, J. Schovánek, D. Karásek

Until recently, obesity was consistently regarded as a factor protecting against the development of osteoporosis. However, newer stu­ dies point to associations between abdominal obesity and decreased bone mineral density, increased fractures and the development of osteoporosis. The associations were reported by both population studies and in vitro experiments. Much attention has been given to communication and interaction between bone and visceral adipose tissues. These are mediated by numerous hormone and cytoki­ nes produced by both tissue types and referred to as a bone-fat axis. Additionally, obese patients suffer from problems such as lower physical activity and inadequate weight loss diet, once again negatively influencing bone tissue. Obesity with higher visceral fat volu­ me is a risk factor for the development of osteoporosis which must be taken into account when caring for obese patients.

Keywords: obesity, osteoporosis Osteologický bulletin 2016, 21(3)89-91

Published: December 11, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Cibičková Ľ, Schovánek J, Karásek D. Is obesity really a protective factor for osteoporosis? Osteologický bulletin. 2016;21(3):89-91.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kado D, Huang M, Karlamangla A, Barrett-Connor E, Greendale G. Hyperkyphotic posture predicts mortality in older community-dwelling men and women: a prospective study. J Am Geriatr Soc 2004;52:1662-1667. Go to original source...
    2. Rossner S. Obesity: the disease of the twenty-first century. Int J Obes Relat Metab Disord 2002;26 (Suppl. 4):S2-S4. Go to original source...
    3. Hu F. Overweight and obesity in women: health risks and consequences. J Women Health (Larchmt) 2003;12:163-172. Go to original source...
    4. Reid IR. Relationships among Body mass, Ins Components, And Bone. Bone 2002;31:547-555. Go to original source...
    5. Akune T, Ohba S, Kamekura S, Yamaguchi M, Chung U, Kubota N et al. PPAR insufficiency enhances osteogenesis through osteoblast formation from bone mar­ row progenitors. J Clin Invest 2004;113:846-855. Go to original source...
    6. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G. Leptin inhibits bone formation through a hy­ pothalamic relay: a central control of bone mass. Cell 2000;100(2):197-207. Go to original source...
    7. Mizuno A, Murakami T, Otani S, Kuwajima M, Shima K. Leptin affects pan­ creatic endocrine functions through the sympathetic nervous system. Endocri­ nology 1998;139(9):3863-3870. Go to original source...
    8. Greco EA, Lenzi A, Migliaccio S. The obesity of bone. Ther Adv Endocrinol Metab 2015;6(6):273-286. Go to original source...
    9. Yang S, Nguyen N, Center J, Eisman J, Nguyen T. Association between abdomi­ nal obesity and fracture risk: a prospective study. J Clin Endocrinol Metab 2013; 98:2478-2483. Go to original source...
    10. Greco E, Francomano D, Fornari R, Marocco C, Lubrano C, Papa V et al. Negative association between trunk fat, insulin resistance and skeleton in obese women. World J Diabetes 2013;4:31-39. Go to original source...
    11. Sogaard A, Holvik K, Omsland T, Tell G, Dahl C, Schei B et al. Abdominal obe­ sity increases the risk of hip fracture. A population-based study of 43,000 women and men aged 60-79 years followed for 8 years. Cohort of Norway. J Intern Med 2015;277:306-317. Go to original source...
    12. Compston J, Flahive J, Hosmer D, Watts N, Siris E, Silverman S et al. Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW). J Bone Miner Res 2014;29:487 493. Go to original source...
    13. Watts N. GLOW investigators. Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW). Nat Rev Endocrinol 2014;10:412-422. Go to original source...
    14. Copes R, Comim F, Langer F, Codevilla A, Sartori G, de Olivera C et al. Obesity and Fractures in Postmenopausal Women: A Primary-care Cross-Sectional Study at Santa Maria, Brazil. J Clin Densitom 2015;18:165-171. Go to original source...
    15. Cohen A, Dempster D, Recker R, Lappe J, Zhou H, Zwahlen A et al. Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study. J Clin Endocrinol Metab 2013;98(6):2562-2572. Go to original source...
    16. Wannenes F, Papa V, Greco E, Fornari R, Marocco C, Baldari C et al. Abdominal Fat and Sarcopenia in Women Significantly Alter Osteoblasts Homeostasis In Vitro by a WNT/ - Catenin Dependent Mechanism. Int J Endocrinol 2014;278316. Go to original source...
    17. Considine R, Sinha M, Heiman M, Kriauciunas A, Stephens T, Nyce M. Serum immunoreactive leptin concentrations in normal weight and obese humans. N Engl J Med 1996;34:292-295. Go to original source...
    18. Thomas T. The complex effects of leptin on bone metabolism through multiple pathways. Curr Opin Pharmacol 2004;4:295-300. Go to original source...
    19. Jurimae J, Rembel K, Jurimae T, Rehand M. Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 2005;37:297-302. Go to original source...
    20. Thommesen L, Stunes A, Monjo M, Grosvik K, Tamburstuen M, Kjobli E et al. Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem 2006;99:824-834. Go to original source...
    21. Wei S, Kitaura H, Zhou P, Ross P, Teitelbaum S. IL-1 mediates TNF-induce osteoclastogenesis. J Clin Invest 2005;115:282-290. Go to original source...
    22. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D et al. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 1991;88:5134-5138. Go to original source...
    23. Palička V. Kostní tkáň a hormony. Postgraduální medicína 2013;15:737-740.
    24. Yoshikawa Y, Kode A, XU L et al. Genetic evidence points to an osteocalcin-in­ dependent influence of osteoblasts on energy metabolism. J Bone Miner Res 2011; 26:2012-2025. Go to original source...
    25. Boucher-Berry C, Speiser PW, Carey DE et al. Vitamin D, Osteocalcin and risk for adiposity as comorbidities in middle school children. J Bone Miner Res 2012; 27:283-293. Go to original source...
    26. Ferris HA, Kahn CR. New mechanisms of glucocorticoid-induced insulin re­ sistance: make no bones about it. J Clin Invest 2012;122:3854-3857. Go to original source...
    27. Zibellini J, Seimon RV, Lee CM, Gibson AA, Hsu MS, Shapses SA, Nguyen TV, Sainsbury A Does Diet-Induced Weight Loss Lead to Bone Loss in Overweight or Obese Adults? A Systematic Review and Meta-Analysis of Clinical Trials. J Bone Miner Res. 2015;30(12):2168-2178. Go to original source...

    Return to the content


    Clinical Osteology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.